Drug · DIN 01900978
REACTINE 20 MG TABLET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 17, 2026; first marketed January 14, 2002.
- Drug Identification Number (DIN)
- 01900978
- Company (DIN owner)
- Kenvue Canada Inc.Guelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Cetirizine R06AE07
- Class
- Human
- Record last updated
- April 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CETIRIZINE HYDROCHLORIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 17, 2026: NOC 37356New Drug Submission (NDS) · Administrative: Change in manufacturer name
- January 23, 2007: NOC 8543New Drug Submission (NDS) · Manufacturer name change
- March 11, 2002: NOC 385New Drug Submission (NDS) · Manufacturer name change